Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - CVS HEALTH Corp | dp27619_ex9901.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant To Section 13 Or 15(d) of The Securities Exchange Act of 1934
|
Date of report (Date of earliest event reported): December 7, 2011
|
||
|
CVS CAREMARK CORPORATION
|
||
|
(Exact name of registrant
as specified in charter)
|
||
|
Delaware
|
001-01011
|
05-0494040
|
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
One CVS Drive, Woonsocket, Rhode Island 02895
|
||
|
(Address of principal executive offices)
|
||
|
Registrant’s telephone number, including area code: (401) 765-1500
|
||
|
(Former name or former address, if changed since last report)
|
||
|
|
||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
| o |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
Item 8.01.
|
Other Events.
|
On December 7, 2011, CVS Caremark Corporation, a Delaware corporation (the “Company”), issued a press release announcing the expiration and final results of its tender offer for any and all of its 6.302% Enhanced Capital Advantaged Preferred Securities. A copy of the press release is attached hereto as Exhibit 99.1.
|
Item 9.01
|
Financial Statements and Exhibits
|
(d) Exhibits
|
Exhibit No.
|
Description
|
|
99.1
|
Press release, dated December 7, 2011, of CVS Caremark Corporation
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
CVS CAREMARK CORPORATION
|
||||||
|
Date:
|
December 7, 2011
|
By:
|
/s/ David M. Denton
|
|||
|
Name:
|
David M. Denton
|
|||||
|
Title:
|
Executive Vice President and Chief Financial Officer
|
|||||